Search results
Novartis (NVS) to Buy MorphoSys & Add Late-Stage Oncology Drug
Zacks via Yahoo News· 5 months agoNovartis NVS announced that it will acquire Germany-based global biopharmaceutical company MorphoSys...
Novartis (NVS) Chronic Myeloid Leukemia Drug Approved by EC
Zacks via Yahoo News· 2 years agoNovartis NVS announced that the European Commission (EC) has approved Scemblix (asciminib) for the...
Novartis (NVS) Q3 Earnings Top, Revenues Miss Estimates
Zacks via Yahoo News· 2 years agoNovartis AG NVS reported mixed third-quarter results for 2022 and revised its guidance for the...
The Zacks Analyst Blog Highlights Novartis, Duke Energy, Boston Scientific, Norfolk Southern and...
Zacks via Yahoo News· 2 years agoFor Immediate Release Chicago, IL – August 1, 2022 – Zacks.com announces the list of stocks featured...
Trending tickers: Glencore | Novartis | Frasers | UBS
Yahoo Finance UK· 1 year agoGlencore makes cash swoop for Teck Resources’ coal business. Photo: Antara Foto/Prasetyo Utomo via...
Top Stock Reports for Procter & Gamble, Novartis & Mondelez International
Zacks via Yahoo News· 8 months agoToday's Research Daily features new research reports on 16 major stocks, including The Procter &...
Top Analyst Reports for Amazon.com, Novartis & Philip Morris
Zacks via Yahoo News· 2 years agoToday's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc....
Drug, Biotech Stocks' Q2 Earnings on Aug 2: GILD, INCY & More
Zacks via Yahoo News· 2 years agoThe earnings season for the pharma sector began when bigwig Johnson & Johnson reported...
Incyte (INCY) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo News· 3 months agoIncyte's (INCY) first-quarter 2024 revenues are likely to have been driven by the U.S. sales and...
Biotech/Drug Stocks' Q1 Earnings Due May 3: UTHR, PCRX & More
Zacks via Yahoo News· 1 year agoQuite a few pharma and biotech bigwigs reported results last week, with the earnings picture looking...